Cargando…

Primary Thymic Hodgkin Lymphoma Coexisting with Thymoma and Myasthenia Gravis: A Case Report

Patient: Female, 24-year-old Final Diagnosis: Myasthenia gravis • thymic Hodgkin’s lymphoma • thymoma Symptoms: Diplopia Clinical Procedure: — Specialty: Surgery OBJECTIVE: Rare disease BACKGROUND: Myasthenia gravis is a neuromuscular disorder that is strongly associated with thymoma. Although the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Almuqbil, Sarah, AlHarbi, Amal, Alzouri, Fatimah S., Elbawab, Hatem Yazeed, Alsafwani, Noor S., Alkhunaizy, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687740/
https://www.ncbi.nlm.nih.gov/pubmed/38006204
http://dx.doi.org/10.12659/AJCR.941792
Descripción
Sumario:Patient: Female, 24-year-old Final Diagnosis: Myasthenia gravis • thymic Hodgkin’s lymphoma • thymoma Symptoms: Diplopia Clinical Procedure: — Specialty: Surgery OBJECTIVE: Rare disease BACKGROUND: Myasthenia gravis is a neuromuscular disorder that is strongly associated with thymoma. Although the presence of myasthenia gravis with other tumors is uncommon, approximately 50% of patients with thymoma have myasthenia gravis. Thymic Hodgkin lymphoma should be considered due to the multiple reported cases of patients with myasthenia gravis and Hodgkin lymphoma. In this report, we present the case of 24-year-old woman with myasthenia gravis who was incidentally found to have coexisting thymoma with thymic Hodgkin lymphoma. CASE REPORT: A 24-year-old woman with a known case of vitiligo presented with a 2-year history of diplopia and incidental anterior mediastinal mass. Following investigations, myasthenia gravis was diagnosed and managed by pyridostigmine, prednisolone, and azathioprine. Regarding the anterior mediastinal mass, thymoma was suspected based on the presence of myasthenia gravis and radiological findings. She underwent extended transsternal thymectomy. The final histopathological report of the dissected thymus disclosed Hodgkin lymphoma pathology coexisting with thymoma. After the diagnosis of Hodgkin lymphoma nodular sclerosis type IIA was confirmed, 6 cycles of chemotherapy were administered. Four years of follow-up revealed no evidence of Hodgkin lymphoma. However, her symptoms of myasthenia gravis persisted despite Hodgkin lymphoma remission. CONCLUSIONS: There is an unclear association between myasthenia gravies and Hodgkin lymphoma. Prior reports revealed regression of myasthenia gravies following Hodgkin lymphoma management, which suggests that myasthenia could be a complication of Hodgkin lymphoma. However, in our case, myasthenia gravis persisted after Hodgkin lymphoma management; therefore, further studies are needed to explore this association.